MediPurpose to Attend Clinical Congress 2019
October 17, 2019MediPurpose shows support for sharps safety at Clinical Congress for the fourth consecutive year
Duluth, Georgia – MediPurpose, a medical products company specializing in sharps safety devices, announced today that it will participate in the American College of Surgeons (ACS) Clinical Congress 2019 in San Francisco, CA from Oct 27 – 31, 2019.
Clinical Congress 2019 offers a highly diversified program of continuing education in all specialties of surgery and in important fields of science, socioeconomics, and medical education. It holds the preeminent place among all College activities designed to raise the standards of surgical practice and improve the care of the surgical patient.
MediPurpose encourages all attendees to stop by booth #306 to view our Anzen Safety Scalpel. MediPurpose is also looking for surgeons passionate about sharps safety to be the champion at their facility and lead product evaluations. All exhibit attendees that fill out a survey form stand a chance to win an Apple Watch.
“We have been attending Clinical Congress without fail since 2016. We find that the feedback we get from the attendees is valuable in understanding our customer’s needs and how to fulfill those needs,” said Patrick Yi, CEO and founder of MediPurpose.
About MediPurpose
MediPurpose, founded in 1999, develops, manufactures, and distributes superior sharps safety devices including the Anzen safety scalpel, SurgiLance safety lancets and MediPlus wound care products. MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose’s Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical products markets. For more information, visit www.medipurpose.com.
Media Contact:
[email protected]